| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $0.5B | $3.3B | $3.5B | $1.0B | $1.0B | $0.8B | $0.9B |
| Cost of Revenue | — | $0.2B | — | — | $0.7B | $0.7B | $0.5B | $0.5B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| SG&A Expense | $0.6B | $0.7B | $0.9B | $0.9B | $0.9B | $1.0B | $1.0B | $1.1B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $-0.0B | $-0.4B | $0.0B | $0.0B | $0.0B | $0.2B | $0.0B |
| EPS (Basic) | $0.84 | $-0.21 | $-2.20 | $0.21 | $0.01 | $0.11 | $1.04 | $0.24 |
| EPS (Diluted) | $0.84 | $-0.21 | $-2.20 | $0.21 | $0.01 | $0.11 | $1.03 | $0.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.2B | $3.4B | $4.3B | $4.7B | $5.0B | $5.2B | $5.5B | $6.0B |
| Current Assets | $1.1B | $1.3B | $1.7B | $1.8B | $1.9B | $2.1B | $2.2B | $2.3B |
| Cash & Equivalents | $0.3B | $0.5B | $0.6B | $0.7B | $0.7B | $0.9B | $0.9B | $0.9B |
| Total Liabilities | $4.0B | $4.0B | $4.6B | $4.7B | $4.8B | $5.2B | $5.2B | $5.7B |
| Current Liabilities | $1.5B | $1.7B | $1.7B | $1.7B | $1.7B | $1.9B | $1.6B | $1.9B |
| Stockholders' Equity | $-0.8B | $-0.6B | $-0.4B | $0.1B | $0.1B | $0.1B | $0.3B | $0.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.2B | — | $0.2B | $0.3B | $0.3B | $0.3B | $0.4B |
| Investing Cash Flow | $-0.1B | $-0.0B | $-0.1B | $-0.0B | $-0.2B | $-0.1B | $0.5B | $0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.2B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.0B | $-0.2B | $-0.3B | $-0.2B | $-0.7B | $-0.8B |